Related Experiment Video
Updated: Apr 5, 2026

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
Published on: June 27, 2015
Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood
K Tamura1, H Wakui, K Azushima
1Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. tamukou@med.yokohama-cu.ac.jp.
Abstract:
Exaggerated activation of the renin-angiotensin system via tissue angiotensin II (Ang II) type 1 receptor (AT1R) signaling exerts detrimental effects on cardiovascular, renal and endocrine systems to provoke hypertension and related target organ damage. On the other hand, accumulated research evidence of both basic and clinical studies shows that physiological AT1R signaling also plays an indispensable role for the normal organ development such as the kidney and the maintenance of cardiovascular and renal homeostasis. Such functional diversity of AT1R signaling prompts us to seek a new strategy of selective modulation of AT1R signaling in pathophysiology. In the course of an investigational search for a means to functionally and selectively modulate AT1R signaling for that purpose, a molecule directly interacting with the carboxyl-terminal cytoplasmic domain of AT1R was identified by employing yeast two-hybrid screening of a mouse kidney cDNA library and named AT1R-associated protein (ATRAP). The results of functional analysis showed that ATRAP promotes constitutive AT1R internalization in cultured cells and inhibits Ang II-mediated pathological response in mouse distal convoluted cells. The ATRAP is expressed in a variety of tissues including the kidney where ATRAP is abundantly distributed in epithelial cells along the renal tubules. The results employing genetic engineered mice with modified ATRAP expression showed that ATRAP plays a key role in the regulation of renal sodium handling and the modulation of blood pressure in response to pathological stimuli such as chronic Ang II infusion, and suggest ATRAP to be a target of interest.
Insights
ATRAP, a novel protein, regulates angiotensin II type 1 receptor (AT1R) signaling. It promotes receptor internalization and inhibits pathological responses, offering a potential therapeutic target for hypertension and organ damage.
Area of Science:
- Cardiovascular Research
- Renal Physiology
- Endocrinology
Background:
- Renin-angiotensin system (RAS) overactivation via angiotensin II type 1 receptor (AT1R) signaling causes hypertension and organ damage.
- Physiological AT1R signaling is crucial for normal kidney development and maintaining cardiovascular/renal homeostasis.
- The dual role of AT1R necessitates selective modulation strategies for therapeutic benefit.
Purpose of the Study:
- To identify novel molecules that selectively modulate AT1R signaling.
- To investigate the functional role of a newly identified protein, ATRAP, in AT1R signaling and related pathophysiology.
Main Methods:
- Yeast two-hybrid screening of a mouse kidney cDNA library to identify AT1R-interacting proteins.
- Functional analysis of ATRAP in cultured cells and mouse models.
- Assessment of ATRAP expression in various tissues, particularly the kidney.
- Utilizing genetically engineered mice with modified ATRAP expression to study its in vivo effects.
Main Results:
- ATRAP was identified as a direct interactor of the AT1R carboxyl-terminal cytoplasmic domain.
- ATRAP promotes constitutive AT1R internalization in cultured cells.
- ATRAP inhibits Ang II-mediated pathological responses in mouse renal cells.
- Genetic modification of ATRAP influenced renal sodium handling and blood pressure regulation in response to pathological stimuli.
Conclusions:
- ATRAP plays a significant role in regulating AT1R signaling.
- ATRAP's ability to inhibit pathological Ang II effects suggests its therapeutic potential.
- ATRAP is a promising target for developing new strategies to manage hypertension and related organ damage.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Potassium-Sparing Diuretics
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of Diuretics

